Healthcare Market Research Companies in MedTech
If you work in medical devices, you have probably landed on a research report that looked comprehensive until you realized it lumped surgical hardware in with drug pipelines, hospital beds, and consumer wearables.
That is the diluted data problem – and it is one of the most common frustrations for product managers, commercial strategists, and corporate development teams in MedTech when evaluating healthcare market research companies.
Below, five firms are grouped not as a flat directory list, but by the specific “superpower” that should drive your vendor decision.
Find growth niches in minutes, not months.
Explore quick, actionable insights from the select markets.
Table of Contents
➜ The Procedure & SKU Specialist: iData Research
➜ The Enterprise RWE Powerhouse: IQVIA
➜ The Facility & Claims Mapper: Definitive Healthcare
➜ The Pipeline & Macro Tracker: GlobalData
➜ The Verified Provider Panel: M3 Global Research
➜ What the Whole Industry Still Gets Wrong
➜ How to Choose Healthcare Market Research Companies for Your MedTech Team
Key Takeaways
- Generic life sciences firms frequently lack the granularity MedTech product teams require for high-stakes commercial decisions.
- The best vendor fit depends on whether you need device-level data, claims-based provider mapping, macro pipeline tracking, or primary qualitative insight.
- iData Research is built bottom-up around procedure volumes and SKU-level pricing, making it the natural fit for device manufacturers who need country-specific competitive intelligence.
- IQVIA dominates large-scale longitudinal datasets but is architected for enterprise pharmaceutical consumption rather than field-rep self-service in MedTech.
- Definitive Healthcare excels at US hospital and provider network mapping – but is deeply US-centric and recently went private, raising questions about roadmap certainty.
- The whole sector still leans too heavily on static quarterly PDFs at a time when MedTech markets move in near real time.
Which firm gives the most granular device and procedure data?
Among healthcare market research companies, iData Research is the firm most purpose-built for that job.
Founded in 2005 and headquartered in Burnaby, British Columbia, iData has specialized in MedTech since inception.
Its coverage spans over 70 countries and more than 50 device categories – from orthopedics and cardiovascular hardware to endoscopy, dental, and diagnostic imaging.
What differentiates iData at a methodological level is its bottom-up approach.
Rather than working top-down from macroeconomic models, analysts combine primary interviews with clinicians and procedure-level volume data to build forecasts that connect device demand to actual clinical activity.
The 10-year market forecasts are validated by clinician feedback, which adds a layer of accuracy that purely claims-based or survey-aggregated models can miss.
Two platform tools extend the research into live commercial use:
- MedSKU – tracks sales by unique product codes (SKUs) across 1,500+ US reporting medical facilities, giving teams SKU-level visibility into unit sales, ASPs, and revenue. It is built from verified purchase order data, making it useful for pricing strategy and competitor monitoring.
- Procedure Tracker – a physician-level tracking service that quantifies over 7,000 procedure types across hospitals, ambulatory surgery centers, and clinics. Teams use it to prioritize sales leads by identifying who is performing what, how often, and where.
iData’s core strength is in devices and procedures.
If your mandate stretches into primary payer dynamics or large-scale HCP behavioral research outside of a device context, that work is handled better elsewhere.
For a broader look at how iData compares against other firms across North America, see the top 7 healthcare market research companies in North America comparison on the iData blog.
Which firm has the largest longitudinal patient dataset for MedTech?
IQVIA is the right answer when the requirement is massive, multi-country real-world evidence (RWE) at the population level.
IQVIA’s Institute for Human Data Science publishes ongoing research on digital health and real-world evidence trends – see their IQVIA Institute reports for macro-level reference.
The firm operates across 100+ countries and maintains one of the largest longitudinal patient datasets in the industry.
Its strength is macro-level commercial analytics – broad post-market surveillance, payer access analysis, and epidemiological trend mapping across large patient cohorts.
IQVIA has a MedTech consulting division and does work in device commercialization, clinical trial support, and regulatory evidence generation.
But its architecture was built for pharmaceutical enterprise consumption.
Teams expecting field-rep-accessible, device-category dashboards often find the platform requires significant implementation effort and internal data science support before it delivers usable output.
Best fit: large-scale post-market surveillance, payer and access strategy, and longitudinal outcomes research where country breadth and patient dataset depth outweigh the need for SKU-level device granularity.
Which firm is best for mapping hospital purchasing networks?
Definitive Healthcare built its platform specifically for commercial sales enablement in the US healthcare system.
Its core product maps hospital purchasing networks, integrated delivery network (IDN) structures, physician referral patterns, and provider-level decision-making hierarchies.
For a MedTech commercial team designing territory coverage or identifying which health systems are actively adopting a specific device category, the platform replaces weeks of manual research with self-service queries.
Additional solutions like Carevoyance (MedTech commercial targeting), Monocl (key opinion leader identification), and Populi (population health analytics) extend the use case further into go-to-market planning.
Two caveats worth noting going into 2026: Definitive Healthcare is deeply US-focused, and the company was taken private by Advent International in 2024.
For teams evaluating long-term platform commitments, roadmap certainty and pricing flexibility are harder to assess for a company no longer subject to public market reporting obligations.
Best fit: US-focused commercial teams that need provider network mapping, hospital and IDN profiling, and territory design intelligence.
Which firm is best for cross-portfolio pipeline tracking in life sciences?
GlobalData is the choice when the strategic question spans both devices and drugs – tracking clinical trial activity, pipeline progression, and broad market sizing across the wider life sciences field in one platform.
Its healthcare platform is designed for high-level strategic decisions: monitoring competitive pipelines, M&A activity, regulatory milestones, and market sizing across dozens of therapy areas simultaneously.
The interface is generally considered easy to navigate, which makes it usable for business development or corporate strategy teams that need quick portfolio-level views rather than deep device category dives.
The trade-off is depth. Where iData drills to the SKU and procedure level within device markets, GlobalData operates at a higher altitude.
It is well suited for cross-industry benchmarking and broad strategic signals, but less so for the granular competitive intelligence that device product managers need to make pricing or launch decisions.
Best fit: corporate strategy and business development teams monitoring pipelines, partnerships, and macro market shifts across both devices and pharma.
Which firm is best for primary qualitative research with physicians?
M3 Global Research is the leader in custom primary research delivered directly through verified healthcare professional (HCP) panels.
Where the other firms on this list are primarily secondary data providers, M3 specializes in collecting first-hand qualitative and quantitative input from physicians, surgeons, nurses, and other clinical specialists.
Its panel is built on verified credentials, which matters significantly when the research question requires input from a specific specialty – say, interventional cardiologists or spinal surgeons – rather than a general healthcare audience.
Best fit: product development and brand strategy teams that need voice-of-customer research, concept testing, or specialist survey data to complement secondary market intelligence.
What do most healthcare market research companies still get wrong?
Across healthcare market research companies as a sector, one structural weakness stands out: most firms still deliver primary intelligence through static quarterly PDF updates.
That cadence was reasonable when market shifts played out over years.
It is increasingly misaligned with how fast MedTech markets now move.
Consider how quickly GLP-1 drug adoption has begun reshaping demand signals in bariatric and cardiovascular device categories – a shift that a quarterly snapshot may record months after commercial teams needed to act on it.
The firms that are building durable long-term trust are those investing in methodology transparency: publishing how data is sourced, how primary interviews are conducted, how forecasts are validated, and how frequently underlying datasets are refreshed.
Buyers increasingly ask for that documentation before signing multi-year contracts, and rightly so.
Dynamic, continuously updated tracking – especially at the procedure and SKU level – is where the next generation of MedTech intelligence is heading.
iData’s MedSKU platform is one example of an effort to close that gap at the device category level.
How to Choose Healthcare Market Research Companies for Your MedTech Team
Selecting among healthcare market research companies starts with locking in definitions and the decisions that data needs to support.
Before evaluating any vendor, a team should answer three questions internally:
- What specific decision does this data need to inform – launch pricing, territory design, pipeline prioritization, post-market surveillance?
- At what level of granularity – country, procedure, device category, SKU, or facility?
- What is the internal capacity to process and act on the data – does the team need analyst support and consulting, or self-service dashboards?
Matching those answers to the firm profiles above narrows the field quickly.
For most MedTech product and commercial teams, the need sits at the intersection of device granularity and procedure-level competitive intelligence – the space where iData Research is most directly built.
For enterprise-scale longitudinal outcomes or broad pipeline monitoring, IQVIA and GlobalData respectively serve those use cases more efficiently.
For a deeper look at how methodology and data transparency should factor into the decision, see the complete healthcare market research companies comparison guide on the iData blog.
Frequently Asked Questions
What makes a healthcare market research company a MedTech specialist?
A true MedTech specialist builds its primary methodology around medical device and procedure data rather than treating devices as a subcategory of a broader life sciences or pharmaceutical research practice.
Indicators include bottom-up procedure-volume modeling, SKU-level pricing data, country-specific device market share, and research coverage that maps to device categories rather than therapy areas primarily defined by drug pipelines.
How is iData Research different from firms like IQVIA or GlobalData?
iData Research focuses exclusively on medical devices, dental, and diagnostics – building its forecasts from primary clinical interviews and procedure-level data rather than top-down macro models.
IQVIA and GlobalData operate at much broader scope, covering pharmaceuticals, drug pipelines, and general life sciences at an enterprise scale that is better suited to large cross-portfolio mandates than granular device market intelligence.
Which healthcare data firm is best for US hospital sales targeting?
Definitive Healthcare is the most purpose-built option for US hospital and provider network mapping, IDN structure analysis, and physician-level commercial targeting.
For procedure-level demand data that feeds into that targeting – understanding which procedures are growing at which facilities – iData’s Procedure Tracker is a complementary tool that many MedTech commercial teams pair with facility-level intelligence.
Do healthcare market research companies cover real-time data?
Most firms in this space still update their primary reports on a quarterly or annual basis.
iData Research’s MedSKU platform is designed to provide more continuous SKU-level sales tracking across US medical facilities, representing one of the closer approximations to real-time device market monitoring currently available from a specialized MedTech intelligence provider.
What is the average selling price (ASP) in MedTech research?
In medical device market research, ASP refers to the average price at which a specific device SKU sells across a defined set of purchasing facilities or geographies.
Tracking ASP over time reveals pricing pressure from competition, reimbursement changes, or shifts in procedure mix.
SKU-level ASP data – the kind iData Research provides through MedSKU – is particularly valuable for product managers making launch pricing decisions or monitoring competitor discounting strategies.
How do I evaluate the methodology of a MedTech research firm?
Ask any prospective vendor to document their primary data collection process, how frequently underlying datasets are refreshed, how forecasts are validated, and what the sample size and credential verification process looks like for any primary research components.
Firms that cannot provide clear answers to those questions represent a meaningful data quality risk for high-stakes commercial decisions.
Turn market painpoints into opportunities
Explore how procedure trends and competitor positioning create clear openings for industry experts in the market.
References
- iData Research – Top 7 Healthcare Market Research Companies in North America 2025
- iData Research – Top Healthcare Market Research Companies: Complete Comparison Guide
- iData Research – MedTech Procedure Tracker
- iData Research – MedSKU and Procedure Tracker Platform Overview
- U.S. FDA – Medical Devices
